{"text": "We report the case of Patient Y0, who has a history of symptoms of anxiety. Examination also revealed a significant decrease in body weight. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 74, "label": "HPO_TERM"}, {"start": 102, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y1, a patient with a face with diminished mimetic function. Further investigation showed bilateral tonic-clonic seizures and a significant decrease in body weight. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 86, "label": "HPO_TERM"}, {"start": 117, "end": 148, "label": "HPO_TERM"}, {"start": 153, "end": 190, "label": "HPO_TERM"}, {"start": 215, "end": 219, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y2, a patient with episodes of intense anxiety. Further investigation showed insufficient liver function and a decrease in body mass. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 156, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y3 were a focal-onset seizure and a weak voice. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "Patient Y4 was evaluated for anxiety. The patient also presented with a focal T2 hyperintense thalamic lesion and a weak voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 36, "label": "HPO_TERM"}, {"start": 70, "end": 108, "label": "HPO_TERM"}, {"start": 113, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y5 were a history of anxiety and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 62, "label": "HPO_TERM"}, {"start": 67, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y6, a patient with a diagnosis of an anxiety disorder. Further investigation showed a focal-onset seizure and decreased liver function. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 78, "label": "HPO_TERM"}, {"start": 109, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 158, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "Patient Y7 was evaluated for a rhythmic shaking movement. The patient also presented with a soft or quiet voice and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 152, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y8, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 93, "label": "HPO_TERM"}, {"start": 121, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y9 includes a history of significant weight loss and anxiety. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 80, "label": "HPO_TERM"}, {"start": 85, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient Y10 was evaluated for a weak voice. The patient also presented with seizures originating in one area of the brain and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 42, "label": "HPO_TERM"}, {"start": 76, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 161, "label": "HPO_TERM"}, {"start": 192, "end": 196, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y11 were a limitation of upgaze and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y12, a patient with a history of anxiety. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 161, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "Patient Y13 was evaluated for a partial seizure. The patient also presented with poverty of facial expression and a limitation of upgaze. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 107, "label": "HPO_TERM"}, {"start": 112, "end": 134, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "Patient Y14 was evaluated for a soft or quiet voice. The patient also presented with a tremor and bilateral tonic-clonic seizures. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 90, "label": "HPO_TERM"}, {"start": 95, "end": 126, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y15, who has a history of a fine tremor. Examination also revealed anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 69, "label": "HPO_TERM"}, {"start": 97, "end": 104, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y16, a patient with a focal-onset seizure. Further investigation showed a soft or quiet voice and seizures originating in one area of the brain. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 165, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y17, a patient with a rhythmic shaking movement. Further investigation showed a partial seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 75, "label": "HPO_TERM"}, {"start": 106, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 165, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y18 were difficulty looking upwards and seizures with a localized origin. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y19, a patient with a focal-onset seizure. Further investigation showed a focal bright signal on T2 MRI of the thalamus and a history of significant weight loss. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 143, "label": "HPO_TERM"}, {"start": 148, "end": 183, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y20 includes difficulty looking upwards and a partial seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y21 includes progressive loss of weight and a tremor. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 84, "label": "HPO_TERM"}, {"start": 110, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y22 were a tremor and seizures originating in one area of the brain. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 124, "end": 128, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y23 were a focal T2 hyperintense thalamic lesion and a soft or quiet voice. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y24, a patient with an unexplained drop in weight. Further investigation showed a weak voice and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 120, "label": "HPO_TERM"}, {"start": 125, "end": 163, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y25 were bilateral tonic-clonic seizures and a focal-onset seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y26, who has a history of a decrease in body mass. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 79, "label": "HPO_TERM"}, {"start": 107, "end": 114, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y27 includes focal seizures and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 85, "label": "HPO_TERM"}, {"start": 111, "end": 115, "label": "GENE_VARIANT"}]}
{"text": "Patient Y28 was evaluated for a tremor. The patient also presented with seizures with a localized origin and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 37, "label": "HPO_TERM"}, {"start": 71, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 151, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y29, who has a history of hypophonia. Examination also revealed a focal T2 hyperintense thalamic lesion. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 66, "label": "HPO_TERM"}, {"start": 94, "end": 132, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient Y30 was evaluated for a focal-onset seizure. The patient also presented with feelings of anxiety and seizures with a localized origin. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 139, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y31, a patient with a weak voice. Further investigation showed a focal-onset seizure and decreased liver function. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 60, "label": "HPO_TERM"}, {"start": 91, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 140, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y32, who has a history of a very quiet speaking voice. Examination also revealed anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 117, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y33, who has a history of a very quiet speaking voice. Examination also revealed a history of anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y34 were focal seizures and progressive loss of weight. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y35, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a focal-onset seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 100, "label": "HPO_TERM"}, {"start": 128, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y36 includes impaired liver function and a focal T2 hyperintense thalamic lesion. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y37, who has a history of anxiety. Examination also revealed a vertical gaze palsy affecting upgaze. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 63, "label": "HPO_TERM"}, {"start": 91, "end": 128, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y38 were anxiety and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "Patient Y39 was evaluated for an expressionless face. The patient also presented with a soft or quiet voice and a simple partial seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 51, "label": "HPO_TERM"}, {"start": 85, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y40 were a rhythmic shaking movement and a tremor. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y41, a patient with a focal-onset seizure. Further investigation showed a vertical gaze palsy affecting upgaze and a weak voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 153, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y42, a patient with a focal T2 hyperintense thalamic lesion. Further investigation showed a partial seizure and a soft or quiet voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 86, "label": "HPO_TERM"}, {"start": 117, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 157, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y43 were a tremor and an involuntary trembling or shaking. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y44 includes feelings of anxiety and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "Patient Y45 was evaluated for a resting tremor. The patient also presented with a diagnosis of focal-onset seizures and a decrease in body mass. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y46 includes a decrease in body mass and poor liver function. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y47 includes anxiety and a simple partial seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y48, a patient with impaired liver function. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 165, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y49 includes a tremor and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 70, "label": "HPO_TERM"}, {"start": 96, "end": 100, "label": "GENE_VARIANT"}]}
{"text": "Patient Y50 was evaluated for weight loss. The patient also presented with bilateral grand mal seizures and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 41, "label": "HPO_TERM"}, {"start": 75, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 128, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y51 were bilateral tonic-clonic seizures and a history of anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "Patient Y52 was evaluated for impaired liver function. The patient also presented with seizures with a localized origin and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "Patient Y53 was evaluated for seizures with a localized origin. The patient also presented with a focal T2 hyperintense thalamic lesion and a soft or quiet voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 61, "label": "HPO_TERM"}, {"start": 95, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y54 were bilateral tonic-clonic seizures and a weak voice. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient Y55 was evaluated for a very quiet speaking voice. The patient also presented with a partial seizure and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "Patient Y56 was evaluated for a focal-onset seizure. The patient also presented with a focal T2 hyperintense thalamic lesion and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 134, "label": "HPO_TERM"}, {"start": 165, "end": 169, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y57 includes difficulty projecting the voice and a focal T2 hyperintense thalamic lesion. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 74, "label": "HPO_TERM"}, {"start": 79, "end": 117, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "Patient Y58 was evaluated for a reduction in facial animation. The patient also presented with paralysis of upward gaze and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 60, "label": "HPO_TERM"}, {"start": 94, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y59, who has a history of a very quiet speaking voice. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 117, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y60, a patient with a focal-onset seizure. Further investigation showed seizures with a localized origin and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 173, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "Patient Y61 was evaluated for seizures with a localized origin. The patient also presented with a soft or quiet voice and seizures with a localized origin. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 61, "label": "HPO_TERM"}, {"start": 95, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y62 includes a mask-like facial expression and a tremor. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 74, "label": "HPO_TERM"}, {"start": 79, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "Patient Y63 was evaluated for a focal-onset seizure. The patient also presented with bilateral grand mal seizures and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 137, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y64 were anxiety and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y65 were a weak voice and a tremor. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 56, "label": "HPO_TERM"}, {"start": 61, "end": 68, "label": "HPO_TERM"}, {"start": 94, "end": 98, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y66, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed seizures originating in one area of the brain. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 164, "label": "HPO_TERM"}, {"start": 219, "end": 223, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y67, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y68 were a decrease in body mass and a focal-onset seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient Y69 was evaluated for a weak voice. The patient also presented with a focal T2 hyperintense thalamic lesion and anxiety. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 42, "label": "HPO_TERM"}, {"start": 76, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 126, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "Patient Y70 was evaluated for a resting tremor. The patient also presented with feelings of anxiety and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y71, who has a history of a very quiet speaking voice. Examination also revealed seizures with a localized origin. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 82, "label": "HPO_TERM"}, {"start": 110, "end": 141, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y72 includes a simple partial seizure and anxiety. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y73, a patient with impaired liver function. Further investigation showed a weak voice and a focal-onset seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 139, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y74 were a focal T2 hyperintense thalamic lesion and a weak voice. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "Patient Y75 was evaluated for a history of significant weight loss. The patient also presented with a partial seizure and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 65, "label": "HPO_TERM"}, {"start": 99, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y76 includes bilateral tonic-clonic seizures and a history of anxiety. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 77, "label": "HPO_TERM"}, {"start": 82, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "Patient Y77 was evaluated for a focal T2 hyperintense thalamic lesion. The patient also presented with a partial seizure and a decrease in body mass. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y78, who has a history of poor liver function. Examination also revealed seizures with a localized origin. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 74, "label": "HPO_TERM"}, {"start": 102, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y79, a patient with a focal-onset seizure. Further investigation showed a focal T2 hyperintense thalamic lesion and anxiety. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 68, "label": "HPO_TERM"}, {"start": 99, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 149, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y80, a patient with a tremor. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 55, "label": "HPO_TERM"}, {"start": 86, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 149, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "Patient Y81 was evaluated for a focal-onset seizure. The patient also presented with a weak voice and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 121, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y82 were a tremor and bilateral tonic-clonic seizures. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 87, "label": "HPO_TERM"}, {"start": 113, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "Patient Y83 was evaluated for a soft or quiet voice. The patient also presented with a partial seizure and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 99, "label": "HPO_TERM"}, {"start": 104, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient Y84 was evaluated for a focal-onset seizure. The patient also presented with a focal T2 hyperintense thalamic lesion and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y85, a patient with impaired liver function. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 165, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y86, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 129, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y87 were a focal-onset seizure and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "Patient Y88 was evaluated for a tremor. The patient also presented with seizures with a localized origin and a soft or quiet voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 37, "label": "HPO_TERM"}, {"start": 71, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 126, "label": "HPO_TERM"}, {"start": 157, "end": 161, "label": "GENE_VARIANT"}]}
{"text": "Patient Y89 was evaluated for a tremor. The patient also presented with anxiety and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 37, "label": "HPO_TERM"}, {"start": 71, "end": 78, "label": "HPO_TERM"}, {"start": 83, "end": 127, "label": "HPO_TERM"}, {"start": 158, "end": 162, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y90 were a tremor and bilateral tonic-clonic seizures. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 87, "label": "HPO_TERM"}, {"start": 113, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "Patient Y91 was evaluated for a focal bright signal on T2 MRI of the thalamus. The patient also presented with feelings of anxiety and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 74, "label": "HPO_TERM"}, {"start": 108, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 176, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y92 includes poor liver function and a focal T2 hyperintense thalamic lesion. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "Patient Y93 was evaluated for bilateral tonic-clonic seizures. The patient also presented with seizures with a localized origin and a partial seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 61, "label": "HPO_TERM"}, {"start": 95, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y94 includes a tremor and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 78, "label": "HPO_TERM"}, {"start": 104, "end": 108, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y95, a patient with impaired liver function. Further investigation showed a focal-onset seizure and a tremor. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 134, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y96 includes a focal T2 hyperintense thalamic lesion and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "Patient Y97 was evaluated for a focal T2 hyperintense thalamic lesion. The patient also presented with a partial seizure and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 68, "label": "HPO_TERM"}, {"start": 102, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 167, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y98, a patient with a focal T2 hyperintense thalamic lesion. Further investigation showed seizures with a localized origin and anxiety. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 86, "label": "HPO_TERM"}, {"start": 117, "end": 148, "label": "HPO_TERM"}, {"start": 153, "end": 160, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y99 includes a weak voice and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y100 were a soft or quiet voice and a focal-onset seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "Patient Y101 was evaluated for a focal T2 hyperintense thalamic lesion. The patient also presented with seizures with a localized origin and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 183, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "Patient Y102 was evaluated for anxiety. The patient also presented with a partial seizure and a soft or quiet voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 112, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "Patient Y103 was evaluated for bilateral grand mal seizures. The patient also presented with a focal T2 hyperintense thalamic lesion and decreased liver function. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 160, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y104, a patient with a focal bright signal on T2 MRI of the thalamus. Further investigation showed a weak voice and feelings of anxiety. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 93, "label": "HPO_TERM"}, {"start": 124, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 160, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y105 were feelings of anxiety and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y106 were a very quiet speaking voice and anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 82, "label": "HPO_TERM"}, {"start": 108, "end": 112, "label": "GENE_VARIANT"}]}
{"text": "Patient Y107 was evaluated for a simple partial seizure. The patient also presented with a tremor and bilateral tonic-clonic seizures. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y108, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 136, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "Patient Y109 was evaluated for bilateral grand mal seizures. The patient also presented with a partial seizure and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 109, "label": "HPO_TERM"}, {"start": 114, "end": 121, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y110 includes bilateral grand mal seizures and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 92, "label": "HPO_TERM"}, {"start": 118, "end": 122, "label": "GENE_VARIANT"}]}
{"text": "Patient Y111 was evaluated for seizures with a localized origin. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 165, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y112 were a tremor and impaired liver function. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 51, "label": "HPO_TERM"}, {"start": 56, "end": 79, "label": "HPO_TERM"}, {"start": 105, "end": 109, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y113, a patient with poor liver function. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 67, "label": "HPO_TERM"}, {"start": 98, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 161, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "Patient Y114 was evaluated for a tremor. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a partial seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 116, "label": "HPO_TERM"}, {"start": 121, "end": 137, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y115, a patient with impaired liver function. Further investigation showed seizures with a localized origin and a focal-onset seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 159, "label": "HPO_TERM"}, {"start": 184, "end": 188, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y116, a patient with a tremor. Further investigation showed bilateral grand mal seizures and seizures originating in one area of the brain. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 56, "label": "HPO_TERM"}, {"start": 87, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 162, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y117 includes a focal T2 hyperintense thalamic lesion and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y118, who has a history of anxiety. Examination also revealed a history of significant weight loss. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 64, "label": "HPO_TERM"}, {"start": 92, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y119 were a weak voice and seizures with a localized origin. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 57, "label": "HPO_TERM"}, {"start": 62, "end": 93, "label": "HPO_TERM"}, {"start": 119, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y120 were a soft or quiet voice and seizures originating in one area of the brain. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 110, "label": "HPO_TERM"}, {"start": 136, "end": 140, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y121 includes a focal-onset seizure and a weak voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 84, "label": "HPO_TERM"}, {"start": 110, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y122 were bilateral tonic-clonic seizures and a history of anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y123, a patient with seizures originating in one area of the brain. Further investigation showed a reduction in facial animation and a weak voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 91, "label": "HPO_TERM"}, {"start": 122, "end": 152, "label": "HPO_TERM"}, {"start": 157, "end": 169, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y124, a patient with a weak voice. Further investigation showed a reduction in facial animation and a partial seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 143, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y125, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed seizures originating in one area of the brain. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 165, "label": "HPO_TERM"}, {"start": 220, "end": 224, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y126, a patient with bilateral tonic-clonic seizures. Further investigation showed a focal-onset seizure and a partial seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 80, "label": "HPO_TERM"}, {"start": 111, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 152, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y127, a patient with a focal T2 hyperintense thalamic lesion. Further investigation showed a history of anxiety and a focal bright signal on T2 MRI of the thalamus. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 186, "label": "HPO_TERM"}, {"start": 211, "end": 215, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y128, who has a history of a decrease in body mass. Examination also revealed a reduction in facial animation. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 80, "label": "HPO_TERM"}, {"start": 108, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y129 were a focal bright signal on T2 MRI of the thalamus and a history of anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "Patient Y130 was evaluated for a focal T2 hyperintense thalamic lesion. The patient also presented with a soft or quiet voice and seizures originating in one area of the brain. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 169, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y131, a patient with seizures originating in one area of the brain. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 91, "label": "HPO_TERM"}, {"start": 122, "end": 142, "label": "HPO_TERM"}, {"start": 147, "end": 185, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "Patient Y132 was evaluated for seizures with a localized origin. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a history of anxiety. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 164, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "Patient Y133 was evaluated for a soft or quiet voice. The patient also presented with a history of anxiety and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y134 includes a focal T2 hyperintense thalamic lesion and a tremor. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y135, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a weak voice. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 141, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "Patient Y136 was evaluated for poor liver function. The patient also presented with seizures with a localized origin and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y137, who has a history of a tremor. Examination also revealed a simple partial seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 64, "label": "HPO_TERM"}, {"start": 92, "end": 114, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "Patient Y138 was evaluated for a partial seizure. The patient also presented with a history of anxiety and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 143, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "Patient Y139 was evaluated for a tremor. The patient also presented with bilateral grand mal seizures and seizures originating in one area of the brain. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y140 were a partial seizure and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y141, who has a history of a soft or quiet voice. Examination also revealed a simple partial seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 126, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "Patient Y142 was evaluated for a focal bright signal on T2 MRI of the thalamus. The patient also presented with a partial seizure and a weak voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 75, "label": "HPO_TERM"}, {"start": 109, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient Y143 was evaluated for bilateral grand mal seizures. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a history of significant weight loss. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 177, "label": "HPO_TERM"}, {"start": 208, "end": 212, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y144, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a focal-onset seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 149, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y145, who has a history of a weak voice. Examination also revealed a decrease in body mass. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 69, "label": "HPO_TERM"}, {"start": 97, "end": 120, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y146 were a focal-onset seizure and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y147 includes a weak voice and a tremor. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 71, "label": "HPO_TERM"}, {"start": 97, "end": 101, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y148, a patient with a weak voice. Further investigation showed a focal-onset seizure and decreased liver function. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 141, "label": "HPO_TERM"}, {"start": 166, "end": 170, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y149 were a focal bright signal on T2 MRI of the thalamus and a decrease in body mass. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 117, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y150, who has a history of a soft or quiet voice. Examination also revealed a focal-onset seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "Patient Y151 was evaluated for a weak voice. The patient also presented with impaired liver function and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 43, "label": "HPO_TERM"}, {"start": 77, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y152 includes a partial seizure and a soft or quiet voice. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 87, "label": "HPO_TERM"}, {"start": 113, "end": 117, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y153 were a focal bright signal on T2 MRI of the thalamus and anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "Patient Y154 was evaluated for a resting tremor. The patient also presented with bilateral grand mal seizures and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 108, "label": "HPO_TERM"}, {"start": 113, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y155 includes a weak voice and seizures originating in one area of the brain. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "Patient Y156 was evaluated for poor liver function. The patient also presented with seizures with a localized origin and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 49, "label": "HPO_TERM"}, {"start": 83, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y157, a patient with a weak voice. Further investigation showed a focal T2 hyperintense thalamic lesion and a focal-onset seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 155, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y158 includes a focal-onset seizure and poor liver function. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y159 were a simple partial seizure and a history of anxiety. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 91, "label": "HPO_TERM"}, {"start": 117, "end": 121, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y160 includes a focal T2 hyperintense thalamic lesion and a partial seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "Patient Y161 was evaluated for a focal bright signal on T2 MRI of the thalamus. The patient also presented with a partial seizure and a weak voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 75, "label": "HPO_TERM"}, {"start": 109, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y162 were difficulty projecting the voice and a focal-onset seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y163 were a history of anxiety and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 63, "label": "HPO_TERM"}, {"start": 68, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y164 were a focal-onset seizure and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "Patient Y165 was evaluated for seizures with a localized origin. The patient also presented with a focal T2 hyperintense thalamic lesion and anxiety. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 146, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "Patient Y166 was evaluated for difficulty projecting the voice. The patient also presented with a focal-onset seizure and a tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 113, "label": "HPO_TERM"}, {"start": 118, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y167, who has a history of a focal bright signal on T2 MRI of the thalamus. Examination also revealed a history of anxiety. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y168, a patient with difficulty projecting the voice. Further investigation showed a focal-onset seizure and a soft or quiet voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 128, "label": "HPO_TERM"}, {"start": 133, "end": 152, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "Patient Y169 was evaluated for seizures with a localized origin. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 140, "label": "HPO_TERM"}, {"start": 145, "end": 165, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y170, a patient with a focal-onset seizure. Further investigation showed a focal bright signal on T2 MRI of the thalamus and a tremor. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 144, "label": "HPO_TERM"}, {"start": 149, "end": 156, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y171, a patient with a weak voice. Further investigation showed a focal-onset seizure and a focal T2 hyperintense thalamic lesion. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 155, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y172 were a tremor and poor liver function. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 75, "label": "HPO_TERM"}, {"start": 101, "end": 105, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y173 includes focal seizures and a focal-onset seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y174, who has a history of a reduction in facial animation. Examination also revealed a weak voice. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 87, "label": "HPO_TERM"}, {"start": 115, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "Patient Y175 was evaluated for a resting tremor. The patient also presented with a soft or quiet voice and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 46, "label": "HPO_TERM"}, {"start": 80, "end": 99, "label": "HPO_TERM"}, {"start": 104, "end": 124, "label": "HPO_TERM"}, {"start": 155, "end": 159, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y176, a patient with a focal bright signal on T2 MRI of the thalamus. Further investigation showed a focal-onset seizure and a weak voice. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 93, "label": "HPO_TERM"}, {"start": 124, "end": 144, "label": "HPO_TERM"}, {"start": 149, "end": 161, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y177, who has a history of a focal-onset seizure. Examination also revealed a focal T2 hyperintense thalamic lesion. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y178 were seizures with a localized origin and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "Patient Y179 was evaluated for a soft or quiet voice. The patient also presented with a partial seizure and seizures with a localized origin. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y180 were a decrease in body mass and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y181, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed a weak voice. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 135, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y182, who has a history of a focal-onset seizure. Examination also revealed a weak voice. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 117, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y183, a patient with impaired liver function. Further investigation showed a focal-onset seizure and a focal bright signal on T2 MRI of the thalamus. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 172, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "Patient Y184 was evaluated for anxiety. The patient also presented with a weak voice and a focal bright signal on T2 MRI of the thalamus. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 133, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "Patient Y185 was evaluated for seizures with a localized origin. The patient also presented with a partial seizure and a soft or quiet voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 112, "label": "HPO_TERM"}, {"start": 117, "end": 136, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y186, who has a history of a focal T2 hyperintense thalamic lesion. Examination also revealed a tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 130, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y187, who has a history of a soft or quiet voice. Examination also revealed a focal-onset seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y188 were seizures with a localized origin and a focal bright signal on T2 MRI of the thalamus. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 124, "label": "HPO_TERM"}, {"start": 150, "end": 154, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y189 were anxiety and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "Patient Y190 was evaluated for a partial seizure. The patient also presented with a focal bright signal on T2 MRI of the thalamus and a focal-onset seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient Y191, a patient with a weak voice. Further investigation showed a focal T2 hyperintense thalamic lesion and a focal-onset seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 32, "label": "PATIENT"}, {"start": 49, "end": 61, "label": "HPO_TERM"}, {"start": 92, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 155, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y192 includes a focal T2 hyperintense thalamic lesion and impaired liver function. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "Patient Y193 was evaluated for seizures originating in one area of the brain. The patient also presented with a focal-onset seizure and a focal T2 hyperintense thalamic lesion. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 73, "label": "HPO_TERM"}, {"start": 107, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 170, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y194 were a partial seizure and a focal T2 hyperintense thalamic lesion. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "Patient Y195 was evaluated for seizures with a localized origin. The patient also presented with a tremor and a weak voice. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 12, "label": "PATIENT"}, {"start": 31, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 120, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y196, who has a history of reduced vocal volume. Examination also revealed unintentional weight loss. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 130, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient Y197 includes bilateral grand mal seizures and weight loss. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 37, "label": "PATIENT"}, {"start": 47, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 91, "label": "HPO_TERM"}, {"start": 117, "end": 121, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient Y198, who has a history of reduced vocal volume. Examination also revealed a diagnosis of focal-onset seizures. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 34, "label": "PATIENT"}, {"start": 57, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 140, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient Y199 were a tremor and bilateral tonic-clonic seizures. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 39, "label": "PATIENT"}, {"start": 45, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}